Symphony Financial’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Symphony Financial's LLY Position: Q2 2026 in Review
Symphony Financial increased its Eli Lilly (LLY) stake by 4% in Q2 2026, buying an estimated $260K and bringing the position to 6,597 shares worth $8.07M. The position accounts for 0.88% of the portfolio, ranked #30.
Symphony Financial first reported a position in LLY in Q1 2021 and has held it in 22 quarters since. 4,618 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Symphony Financial held 6,597 shares of Eli Lilly worth $8.07M as of Q2 2026.
- Symphony Financial bought 254 Eli Lilly shares in Q2 2026, an estimated $260K.
- Eli Lilly made up 0.88% of Symphony Financial's portfolio in Q2 2026, its #30 holding.
- Symphony Financial first reported a position in Eli Lilly in Q1 2021 and has held it in 22 quarters since.
- 4,618 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Symphony Financial's 13F filing for Q2 2026, filed 4 Aug 2026.